• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Problems posed by secondary peritoneal carcinosis of digestive origin].

作者信息

Le Néel J C, Douillard J Y, Dupas B, Letessier E, Borde L, Eloufir M, Armstrong O

机构信息

C.H.U., Hôtel-Dieu, Nantes.

出版信息

Chirurgie. 1994;120(3):134-7; discussion 137-8.

PMID:7729226
Abstract

Secondary peritoneal carcinoma occurs in cases of malignant bowel disease after the initial curative operation or rarely after palliative surgery. The main problems are frequent overshoot in the diagnosis and correct management. Based on our experience with 101 patients with secondary peritoneal carcinoma treated over the last 10 years, we determined the therapeutic possibilities. In 23% of the cases no surgery was possible and in only 4% underwent a second palliative operation. Survival was basically dependent on the initial malignant disease. More aggressive therapeutic methods are currently under study.

摘要

相似文献

1
[Problems posed by secondary peritoneal carcinosis of digestive origin].
Chirurgie. 1994;120(3):134-7; discussion 137-8.
2
[Surgery associated with intraoperative hyperthermia-chemotherapy in the treatment of malignant tumors of the digestive system with peritoneal carcinosis].术中热化疗联合手术治疗伴有腹膜转移的消化系统恶性肿瘤
G Chir. 1999 May;20(5):241-5.
3
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].[细胞减灭术联合腹腔热灌注化疗(IHPC)治疗腹膜癌病:术后发病率、死亡率及短期随访]
Ann Ital Chir. 2008 Jul-Aug;79(4):231-9.
4
[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].[细胞减灭术及腹腔内热灌注化疗(HAPP)治疗腹膜癌病]
Minerva Chir. 2002 Oct;57(5):597-605.
5
[Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis].
G Chir. 2004 Jan-Feb;25(1-2):43-6.
6
[Peritoneal carcinosis treated by complete excision and immediate postoperative intra-peritoneal chemotherapy. Phase II study in 54 patients].[通过完全切除及术后即刻腹腔内化疗治疗腹膜癌。54例患者的II期研究]
Gastroenterol Clin Biol. 1997;21(3):181-7.
7
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.结直肠癌腹膜转移患者接受细胞减灭术及热灌注腹腔化疗与全身化疗及姑息性手术的随机试验
J Clin Oncol. 2003 Oct 15;21(20):3737-43. doi: 10.1200/JCO.2003.04.187.
8
The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.单纯减瘤手术在结直肠癌源性腹膜癌治疗中的作用。关于多模式治疗的回顾性分析。
Hepatogastroenterology. 2009 May-Jun;56(91-92):650-5.
9
[Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data].[腹腔内热化疗治疗卵巢源性腹膜癌病。初始病例及病理生理数据]
J Gynecol Obstet Biol Reprod (Paris). 1993;22(4):369-71.
10
[Digestive surgery in patients over 80 years of age. Apropos of 690 operations].80岁以上患者的消化外科手术。关于690例手术
Ann Chir. 1992;46(10):923-7.